Penobscot Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $352K | Hold |
670
| – | – | 0.03% | 249 |
|
2025
Q1 | $425K | Hold |
670
| – | – | 0.04% | 222 |
|
2024
Q4 | $477K | Hold |
670
| – | – | 0.04% | 209 |
|
2024
Q3 | $704K | Hold |
670
| – | – | 0.06% | 183 |
|
2024
Q2 | $704K | Hold |
670
| – | – | 0.07% | 179 |
|
2024
Q1 | $645K | Sell |
670
-4
| -0.6% | -$3.85K | 0.07% | 185 |
|
2023
Q4 | $592K | Hold |
674
| – | – | 0.07% | 187 |
|
2023
Q3 | $555K | Hold |
674
| – | – | 0.08% | 174 |
|
2023
Q2 | $484K | Hold |
674
| – | – | 0.08% | 156 |
|
2023
Q1 | $554K | Sell |
674
-375
| -36% | -$308K | 0.1% | 148 |
|
2022
Q4 | $757K | Hold |
1,049
| – | – | 0.13% | 129 |
|
2022
Q3 | $723K | Hold |
1,049
| – | – | 0.13% | 130 |
|
2022
Q2 | $620K | Hold |
1,049
| – | – | 0.11% | 145 |
|
2022
Q1 | $733K | Hold |
1,049
| – | – | 0.11% | 147 |
|
2021
Q4 | $662K | Buy |
1,049
+124
| +13% | +$78.3K | 0.09% | 153 |
|
2021
Q3 | $560K | Hold |
925
| – | – | 0.08% | 157 |
|
2021
Q2 | $517K | Buy |
925
+250
| +37% | +$140K | 0.08% | 158 |
|
2021
Q1 | $319K | Hold |
675
| – | – | 0.05% | 192 |
|
2020
Q4 | $326K | Hold |
675
| – | – | 0.05% | 180 |
|
2020
Q3 | $378K | Sell |
675
-125
| -16% | -$70K | 0.07% | 155 |
|
2020
Q2 | $499K | Hold |
800
| – | – | 0.1% | 138 |
|
2020
Q1 | $391K | Hold |
800
| – | – | 0.09% | 141 |
|
2019
Q4 | $300K | Hold |
800
| – | – | 0.06% | 171 |
|
2019
Q3 | $222K | Hold |
800
| – | – | 0.04% | 188 |
|
2019
Q2 | $250K | Hold |
800
| – | – | 0.05% | 179 |
|
2019
Q1 | $328K | Hold |
800
| – | – | 0.07% | 160 |
|
2018
Q4 | $299K | Buy |
800
+100
| +14% | +$37.4K | 0.07% | 156 |
|
2018
Q3 | $283K | Hold |
700
| – | – | 0.06% | 176 |
|
2018
Q2 | $241K | Hold |
700
| – | – | 0.06% | 187 |
|
2018
Q1 | $241K | Hold |
700
| – | – | 0.06% | 188 |
|
2017
Q4 | $263K | Hold |
700
| – | – | 0.07% | 169 |
|
2017
Q3 | $313K | Hold |
700
| – | – | 0.09% | 153 |
|
2017
Q2 | $344K | Hold |
700
| – | – | 0.11% | 146 |
|
2017
Q1 | $271K | Hold |
700
| – | – | 0.09% | 155 |
|
2016
Q4 | $257K | Hold |
700
| – | – | 0.09% | 157 |
|
2016
Q3 | $281K | Hold |
700
| – | – | 0.1% | 153 |
|
2016
Q2 | $244K | Hold |
700
| – | – | 0.09% | 162 |
|
2016
Q1 | $252K | Hold |
700
| – | – | 0.09% | 161 |
|
2015
Q4 | $380K | Hold |
700
| – | – | 0.12% | 143 |
|
2015
Q3 | $326K | Hold |
700
| – | – | 0.11% | 150 |
|
2015
Q2 | $357K | Hold |
700
| – | – | 0.11% | 157 |
|
2015
Q1 | $316K | Hold |
700
| – | – | 0.1% | 157 |
|
2014
Q4 | $287K | Hold |
700
| – | – | 0.09% | 157 |
|
2014
Q3 | $252K | Buy |
+700
| New | +$252K | 0.08% | 161 |
|